![Albert Tsai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Albert Tsai is Chief Medical Officer at VivaVision Biotech (Zhejiang) Co., Ltd. since 2025.
Formerly, Dr. Tsai was Vice President at PPD, Inc. from 2019 to 2021 and Chief Medical Officer at Zhaoke Ophthalmology Ltd. Education includes an MBA from the University of Southern California and a doctorate from Northwestern University.
Cargos activos de Albert Tsai
| Empresas | Cargo | Inicio |
|---|
Antiguos cargos conocidos de Albert Tsai.
| Empresas | Cargo | Fin |
|---|---|---|
| PPD, INC. | Corporate Officer/Principal | 01/01/2021 |
| ZHAOKE OPHTHALMOLOGY LIMITED | Director Técnico/Científico/I+D | - |
Formación de Albert Tsai.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
14
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PPD, Inc.
 PPD, Inc. BiotechnologyHealth Technology Engages in research and development of biopharmaceutical industry | Health Technology |
Zhaoke Ophthalmology Ltd.
 Zhaoke Ophthalmology Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies ophthalmic topical drugs | Health Technology |
- Bolsa de valores
- Insiders
- Albert Tsai
